Table 2.
Crude mortality of HIV/MTB co-infection across 60 months by treatment outcomes
| Treatment outcomes | Case number (%) | Mortality in 6 months (%) | Mortality in 12 months (%) | Mortality in 24 months (%) | Mortality in 36 months (%) | Mortality in 48 months (%) | Mortality in 60 months (%) | χ2 | P value |
|---|---|---|---|---|---|---|---|---|---|
| Adverse events, failure, missing | 382 (16.25) | 157 (41.10) | 187 (48.95) | 212 (55.50) | 222 (58.12) | 227 (59.42) | 229 (59.95) | 107.8 | < 0.0001 |
| Complete treatment | 1289 (54.83) | 150 (11.64) | 242 (18.77) | 315 (24.44) | 379 (29.4) | 404 (31.34) | 413 (32.04) | – | – |
| Cure | 680 (28.92) | 85 (12.50) | 126 (18.53) | 164 (24.12) | 192 (28.24) | 206 (30.29) | 217 (31.91) | – | – |
Abbreviation: IRQ Interquartile Range; IDU Injection drugs users; ART Antiretroviral therapy